Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Global Disposable Surgical Devices Markets, 2021-2028 - Demand for Surgical Sealants and Glues & Pricing Pressures Restraining Growth


DUBLIN, Nov. 30, 2021 The "Global Disposable Surgical Devices Market Size, Share & Trends Analysis Report by Product, by Application (General Surgery, Plastic & Reconstructive Surgery), and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global disposable surgical devices market size is expected to reach USD 9.3 billion by 2028 and is expected to expand at a CAGR of 7.8% from 2021 to 2028.

The growing prevalence of chronic diseases, such as cardiovascular, neurological, urological, and infectious disorders, is expected to drive the overall market. Chronic diseases are a global healthcare concern, with over half of the adult population in the U.S. suffering from them, resulting in over 75% of the total healthcare expenditure. Thus, a rise in infectious and chronic diseases is expected to create a significant demand for disposable surgical devices.

Cancer has become a significant healthcare burden and a leading cause of death across the globe. According to the WHO, almost 1 in 6 deaths can be attributed to this disease. Estimates from the same source indicate that over 70% of cancer-related deaths typically occur in middle- and low-income countries. Thus, a steady rise in the number of curative, preventive, and diagnostic cancer surgeries has been observed globally, creating a high demand for disposable surgical equipment.

The growing number of road accidents is expected to augment the demand for disposable surgical instruments. According to the WHO, around 10 million people are injured or disabled due to road accidents every year, creating a demand for surgeries. Such wounds are commonly managed using surgical sutures. Hence, the increasing number of road accidents is expected to positively impact demand for disposable surgical sutures and staplers.

The increasing government initiatives for the usage of disposable medical devices to avoid hospital-associated infections are expected to boost the usage of single-use devices. The growing number of surgical procedures is expected to increase the need for disposable surgical devices.

Disposable Surgical Devices Market Report Highlights

Disposable Surgical Devices Market Variables, Trends & Scope

Market driver analysis

Market restraint analysis

Industry challenges

Market Lineage Outlook

Penetration & Growth Prospect Mapping

Industry Value Chain Analysis

Disposable Surgical Devices Market Analysis Tools

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/xw7p26

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 03:41
Apollon Formularies plc (AQSE: APOL) ("Apollon" or the "Company"), a UK based international medical cannabis pharmaceutical company trading on AQSE Growth Market, is pleased to announce the appointment of Dr. Herbert Fritsche to the Board of...

at 03:01
Nova Mentis Life Science Corp. ("NOVA" or the "Company"), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders is proud to announce that the Company...

at 03:00
SiSaf Ltd, a company developing RNA therapeutics for rare genetic skeletal disorders, today announced that it has appointed Professor Michael J. Econs, MD as Clinical Advisor. Distinguished Professor of Medicine and Medical and Molecular Genetics at...

at 03:00
iSwap, a cross-chain transaction platform, announced the launch of iSwap V5, the latest upgrade to its system today. Through this upgrade, iSwap aims to improve the user experience for cross-chain DeFi transactions. The upgrade consists of two...

at 03:00
NJ Top Docs has reviewed and approved Dr. Cherag Daruwala of Hunterdon Gastroenterology Associates for 2021. This is Dr. Daruwala's sixth consecutive year being reviewed and approved by NJ Top Docs. Dr. Daruwala is a board certified...

at 02:23
Ready to capitalize on a strong foundation Q4 2021 highlights Total net revenues of SEK 144.0 m (159.2) Net earnings of SEK -66.0 m (-49.6) EBITDA of SEK -48.5 m (1.0) US Pharma segment (ZUBSOLV® US) net revenues of SEK 133.6 m (143.1), in local...



News published on 30 november 2021 at 16:15 and distributed by: